Track topics on Twitter Track topics that are important to you
The post UCB acquires Ra Pharma for $2.1bn to enrich its rare disease portfolio appeared first on Pharmaceutical Technology.
Original Article: UCB acquires Ra Pharma for $2.1bn to enrich its rare disease portfolioNEXT ARTICLE
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...